NCT03232125View on ClinicalTrials.gov

Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

June 9, 2020

Study Completion Date

June 12, 2020

Conditions
Prostate Cancer
Interventions
DRUG

Ramosetron

Randomly selected patients of the ramoseton group are given a 0.3 mg of ramosetron after induction.

DRUG

Normal saline

In contrast, patients in the control group are given the same volume of normal saline after induction and given a 0.3 mg of ramosetron after measurement of QTc interval.

Trial Locations (1)

03722

Professor, Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03232125 - Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position | Biotech Hunter | Biotech Hunter